C-TAP (WHO COVID-19 Technology Access Pool) welcomes the open pledge by 18 generic pharmaceutical companies to join the Medicines Patent Pool and take collective action against COVID-19. This is a critical commitment to ensure all populations around the world have access to affordable health products as soon they need them.
We now encourage technology holders, public and private, to voluntarily share COVID-19-related knowledge, intellectual property and data in line with the principles of the Solidarity call to action with public health organizations like the Medicines Patent Pool, the Tech Access Partnership, or the Open COVID Pledge working in partnership with C-TAP.
C-TAP aims to help accelerate the development and manufacturing scale-up of health products needed to fight COVID-19 and the removal of barriers to access in order to make products available globally and equitably.